80 related articles for article (PubMed ID: 16647239)
1. The effect of dendritic cells activated by OK-432 and pulsed with antigens on cytokine induced killers.
Shu YQ; Gu Y
Biomed Pharmacother; 2006 May; 60(4):156-60. PubMed ID: 16647239
[TBL] [Abstract][Full Text] [Related]
2. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Nakamori M; Ueda K; Naka T; Katsuda M; Miyazawa M; Iida T; Yamaue H
Int J Oncol; 2008 Feb; 32(2):459-66. PubMed ID: 18202769
[TBL] [Abstract][Full Text] [Related]
3. Mature dendritic cells generated from patient-derived peripheral blood monocytes in one-step culture using streptococcal preparation OK-432 exert an enhanced antigen-presenting capacity.
Naito K; Ueda Y; Itoh T; Fuji N; Shimizu K; Yano Y; Yamamoto Y; Imura K; Kohara J; Iwamoto A; Shiozaki A; Tamai H; Shimizu T; Mazda O; Yamagishi H
Int J Oncol; 2006 Jun; 28(6):1481-9. PubMed ID: 16685449
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 polyunsaturated fatty acids affect lipopolysaccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38.
Wang H; Hao Q; Li QR; Yan XW; Ye S; Li YS; Li N; Li JS
Nutrition; 2007 Jun; 23(6):474-82. PubMed ID: 17499970
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells.
Erhardt M; Schmidt-Wolf IG; Sievers E; Frank S; Strehl J; von Lilienfeld-Toal M; Gorschlüter M
Arch Immunol Ther Exp (Warsz); 2006; 54(6):403-9. PubMed ID: 17122879
[TBL] [Abstract][Full Text] [Related]
6. Understanding the response of dendritic cells to activation by streptococcal preparation OK-432.
Kanzaki N; Terashima M; Kashimura S; Hoshino M; Ohtani S; Matsuyama S; Hoshino Y; Kogure M; Oshibe I; Endo H; Saito T; Yaginuma H; Gotoh M; Ohto H
Anticancer Res; 2005; 25(6B):4231-8. PubMed ID: 16309221
[TBL] [Abstract][Full Text] [Related]
7. An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways.
Lin YL; Liang YC; Tseng YS; Huang HY; Chou SY; Hseu RS; Huang CT; Chiang BL
J Leukoc Biol; 2009 Oct; 86(4):877-89. PubMed ID: 19498044
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.
Tanaka A; Minoguchi K; Samson KT; Oda N; Yokoe T; Tazaki T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2007 Jul; 37(7):1083-9. PubMed ID: 17581203
[TBL] [Abstract][Full Text] [Related]
9. [Effect of HBsAg pulsed dendritic cells on the functions of cytokine-induced killer cells].
Liu SR; Zhang Y; Xie Q; Li ZL; Yu ZY; Kong XP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):634-6. PubMed ID: 16143074
[TBL] [Abstract][Full Text] [Related]
10. Biological effect of OK-432 (picibanil) and possible application to dendritic cell therapy.
Ryoma Y; Moriya Y; Okamoto M; Kanaya I; Saito M; Sato M
Anticancer Res; 2004; 24(5C):3295-301. PubMed ID: 15515424
[TBL] [Abstract][Full Text] [Related]
11. [Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD; Zhang WY; Yuan CL; Han LY
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):630-4. PubMed ID: 19595165
[TBL] [Abstract][Full Text] [Related]
12. Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta.
Zhang LF; Okuma K; Tanaka R; Kodama A; Kondo K; Ansari AA; Tanaka Y
Exp Biol Med (Maywood); 2008 Jun; 233(6):721-31. PubMed ID: 18408138
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligation during dendritic cell maturation reduces cell death and prevents interleukin-10-induced regression to macrophage-like monocytes.
Haenssle H; Buhl T; Knudsen S; Krueger U; Rosenberger A; Reich K; Neumann C
Exp Dermatol; 2008 Mar; 17(3):177-87. PubMed ID: 18081852
[TBL] [Abstract][Full Text] [Related]
14. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of immunomodulators for maturation of dendritic cells.
Ogihara T; Iinuma H; Okinaga K
Int J Oncol; 2004 Aug; 25(2):453-9. PubMed ID: 15254744
[TBL] [Abstract][Full Text] [Related]
16. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
17. OK-432 synergizes with IFN-γ to confer dendritic cells with enhanced antitumor immunity.
Pan K; Lv L; Zheng HX; Zhao JJ; Pan QZ; Li JJ; Weng DS; Wang DD; Jiang SS; Chang AE; Li Q; Xia JC
Immunol Cell Biol; 2014 Mar; 92(3):263-74. PubMed ID: 24296809
[TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands.
Dowling D; Hamilton CM; O'Neill SM
Cytokine; 2008 Mar; 41(3):254-62. PubMed ID: 18221884
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?
Prutchi Sagiv S; Lifshitz L; Orkin R; Mittelman M; Neumann D
Exp Hematol; 2008 Dec; 36(12):1682-90. PubMed ID: 18922618
[TBL] [Abstract][Full Text] [Related]
20. Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor.
Liu CC; Wang YS; Lin CY; Chuang TF; Liao KW; Chi KH; Chen MF; Chiang HC; Chu RM
Cancer Immunol Immunother; 2008 Apr; 57(4):479-91. PubMed ID: 17710396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
